Precision Scientific (China) key facts
as of Oct 2026- Provider of AIBERT, an AI-native poly-omics exploration engine intended for novel medicine R&D and clinic-facing translation.
- Precision Scientific (China) is valued at approximately $126.3M as of Oct 2026 (last reported valuation).
- It has raised $48.6M; the latest was Later Stage VC ($14.1M) in Dec 2025.
- Notable investors include SND Ventures Group, Baidu Ventures, Sinovation Ventures, CDBI Partners, Shenzhen GTJA Investment Group — 13 tracked in total.
- Status: Privately Held (backing).
Precision Scientific (China)'s last reported valuation, Jun 2023. Nothing priced has surfaced since.
- ·The complete investor list: 13 names
- ·Watch Precision Scientific (China): the Monday email on marks, rounds and moves
Precision Scientific (China) funding rounds
No funding rounds for Precision Scientific (China) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Precision Scientific (China)
13+Precision Scientific (China) valuation
Precision Scientific (China)'s last reported valuation was $126 million in Jun 2023. No priced round, secondary trade or fund mark has surfaced since.
Precision Scientific (China) investors
13 investors are on record for Precision Scientific (China), including SND Ventures Group, Baidu Ventures, Sinovation Ventures and CDBI Partners.
About Precision Scientific (China)
Provider of AIBERT, an AI-native poly-omics exploration engine intended for novel medicine R&D and clinic-facing translation. The company provides mode-of-action mapping, signature derivation, trial design guidance, biostatistics, core laboratory operations, and companion assay co-development, enabling biopharma industry users with faster approval-track solutions.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2015
- Website
- precisionscientific.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.